Data Curation and Entry in DIDB – September Summary

In September, we added 118 citations in DIDB, including 56 in vitro (with 29 articles published in Sept. 2021) and 62 in vivo articles (with 35 articles published in Sept. 2021).

Four recently approved NDAs/BLAs were also added with the 2 following NDAs: ibrexafungerp (BREXAFEMME) and viloxazine (QELBREE) and 2 following BLAs: asparaginase erwinia (RYLAZE) and avalglucosidase alfa (NEXVIAZYME).

You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.

As always, feel free to contact us if you have any questions or comments.